Pretraživanje
Prikaz rezultata 11-18 od 18
B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice
(Rockefeller Univ Press, New York, 2003)
Mice deficient for the transcriptional coactivator BOB.1/OBF.1 show several defects in B cell differentiation. Numbers of immature transitional B cells in the bone marrow are reduced and fewer B cells reach the periphery. ...
The IKK2/NF-kappa B pathway suppresses MYC-induced lymphomagenesis
(Amer Soc Hematology, Washington, 2009)
Deregulated c-MYC is found in a variety of cancers where it promotes proliferation as well as apoptosis. In many hematologic malignancies, enhanced NF-kappa B exerts prosurvival functions. Here we investigated the role of ...
BOB.1OBF.1 deficiency affects marginal-zone B-cell compartment
(Amer Soc Microbiology, Washington, 2002)
Marginal-zone (MZ) B cells represent a first line of defense against particulate blood-borne antigens. Together with the B1 cells, they are responsible for the early response against type It T-independent antigens. The ...
Detection and prevalence of motor skill disorders
(Pergamon-Elsevier Science Ltd, Oxford, 2009)
The main goal of this research was to establish the prevalence, form of manifestation, level and kind of motor skill disorders in three area of motor development functioning: neuromaturation, coordination and balance. The ...
Analysis of voice impairment in aphasia after stroke-underlying neuroanatomical substrates
(Academic Press Inc Elsevier Science, San Diego, 2012)
Phonation is a fundamental feature of human communication. Control of phonation in the context of speech-language disturbances has traditionally been considered a characteristic of lesions to subcortical structures and ...
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
(Elsevier Science Inc, New York, 2020)
Background More than a third of patients with epilepsy are treatment resistant, and thus new, more effective therapies to achieve seizure freedom are needed. Cenobamate (YKP3089), an investigational antiepileptic drug, has ...
Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: A cross-sectional survey
(Elsevier B.V., 2013)
Background Depression is the third leading contributor to the worldwide burden of disease. We assessed the nature and severity of experienced and anticipated discrimination reported by adults with major depressive disorder ...
Cross-national variations in reported discrimination among people treated for major depression worldwide: The ASPEN/INDIGO international study
(Royal College of Psychiatrists, 2015)
Background: No study has so far explored differences in discrimination reported by people with major depressive disorder (MDD) across countries and cultures. Aims: To (a) compare reported discrimination across different ...